vivi
Lv7
4440 积分
2022-09-16 加入
-
Sodium-glucose cotransporter 2 inhibitors and renal cancer in the US FDA adverse event reporting system
3天前
已完结
-
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
13天前
已完结
-
Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies
1个月前
已完结
-
Gout in China, 1990-2017: the Global Burden of Disease Study 2017
1个月前
已完结
-
A Phase 3 prospective, multi-center, double-blind, randomized trial of saroglitazar 4 mg compared to placebo in patients with non-alcoholic steatohepatitis
2个月前
已关闭
-
Low acid uric in primary prophylaxis: worthy?
2个月前
已完结
-
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
2个月前
已完结
-
Evaluating the drug-drug interactions of SHR4640 on repaglinide and midazolam in healthy subjects
2个月前
已完结
-
Liraglutide and Liver Injury: Rare Case Report with Literature Review
2个月前
已完结
-
A very rare cause of markedly elevated CA 19–9: Glucagon-like peptide-1 receptor agonists
2个月前
已完结